"Close legal loophole" for circumventing diagnostics PMAs (premarket approvals)
This article was originally published in Clinica
A well-known FDA lawyer has asked the agency to wield its warning letter authority to stop certain diagnostic manufacturers from abusing a regulatory loophole in order to avoid having to go through the agency's premarket review process.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.